Development of the LCMS bioanalysis for antibody drug monitoring in plasma using Fab-selective limited proteolysis (nSMOL)

Takashi Shimada

Presentation information

Symposium

Symposium14「Recent Progress of the biologics analysis」

Sat. Nov 14, 2015 9:30 AM - 12:00 PM Room B (5ＦＳｍａｌｌＨａｌｌ)

Organizers:Masahiro Utoh (Pharmacokinetics and Bioanalysis Center, Shin Nippon Biomedical Laboratories, Ltd.), Takashi Kuwabara (Translational Research Unit, R&D Division, Kyowa Hakko Kirin Co., Ltd.), Chairs:Fujiko Takamura (Analysis & Pharmacokinetics Research Labs, Pharmacokinetics-Pharmacodynamics, Astellas Pharma Inc.), Jun Hosogi (Translational Research Unit, R&D Division, Kyowa Hakko Kirin Co.,Ltd)

[SY-14-04] Development of the LCMS bioanalysis for antibody drug monitoring in plasma using Fab-selective limited proteolysis (nSMOL)

^○Takashi Shimada ¹, Noriko Iwamoto ¹, Naoe Yamane ³, Akinobu Hamada ² (1.Life Science Research Center, SHIMADZU Corporation, 2.Division of Clinical Pharmacology & Translational Research, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, 3.New technology development office, CMIC Pharma Science Co., Ltd.)

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.